Institutional Cluster

KOD

Kodiak Sciences Inc.
BULLISH
Impact 4/10
Horizonmonths Processed3mo ago
Institutional cluster: 4 buyers, 1 sellers (bullish)
Actionable Insight ▲ Bullish

The cluster shows clear passive-accumulation conviction but lacks a fundamental catalyst (no revenue, earnings, or pipeline event). Given the model's negative historical track record on KOD calls and the passive-dominated buyer list, treat this as a modest confidence signal, not a strong buy indicator. Monitor upcoming quarterly results and any pipeline data releases for confirmation that the thesis is intact.

DirectionBullish
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
KOD ▲ +4.09% at T+60d
LONG call ✓ call won +4.09% · α vs SPY -0.30% · entry $33.97 → $35.36
Entry anchored
Jun 11, 06:50 AM ET
via exchange tick
T+1d
+0.26%
call +0.26% · α -0.28%
$34.06
settled 4mo ago
T+5d
+5.12%
call +5.12% · α +4.69%
$35.71
settled 4mo ago
T+20d
+17.99%
call +17.99% · α +16.10%
$40.08
settled 3mo ago
T+60d
+4.09%
call +4.09% · α -0.30%
$35.36
settled 24d ago

Executive Summary

Four mega-passive institutional investors (T. Rowe Price, Invesco, BofA, Morgan Stanley) aggressively accumulated Kodiak Sciences shares in Q3 2025, with total reported buying of $17.3M versus one seller (RenTech trimming $4.7M). Despite the bullish accumulation, the filing does not contain any fundamental catalyst — the activity is dominated by passive index/quant rebalancing, and the net $16.0M increase is modest relative to KOD's $2B market cap (~0.8%). Historical calibration for this segment shows low win rates at observed impact scores (34% at score 6, 27% at score 8) with negative net alpha, underscoring a poor track record for the model's prior KOD reports.

Key Financial Metrics

Direction
accumulating
Buy Value
$17.3M
Sell Value
$4.7M
Net Flow
$12.6M

Institutional Positions

Net institutional flow: $12.6M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
T. Rowe PriceDOUBLED+1202.4%$8.0K$7.9K
InvescoADD+30.3%$1.6M$1.4M
BofADOUBLED+657.7%$5.1M$4.9M
Morgan StanleyDOUBLED+165.8%$10.6M$9.7M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
RenTechTRIM-39.6%$2.9M-$4.7M

Key Facts

  • Four mega-passive institutions accumulated $17.3M in KOD shares in Q3 2025, a net increase of $16.0M
  • RenTech trimmed its position by 39.6% (from 764.1K to 461.3K shares), but the dollar value of its remaining holding increased to $7.6M (up $4.7M from $2.9M)
  • Morgan Stanley doubled its position from 243.6K to 647.6K shares, adding $9.7M in value — the largest single buyer
  • BofA added 268.3K shares (+657.7%), T. Rowe Price added 463.7K shares (+1202.4%)
  • All buyers are mega-passive/quant funds (no active value, activist, or hedge fund managers), weakening the signal
  • The aggregate buying represents roughly 0.8% of KOD's $2B market cap, a modest fraction
  • Historical model performance on KOD reports has been poor (avg T+20 alpha -18.85%, 33% win rate across 3 settled reports)

Financial Impact

4 institutions accumulated $17.3M in new positions while 1 institution reduced holdings by $4.7M (dollar value still increased due to price appreciation). Net institutional inflow of approximately $11.3M, or ~0.6% of market cap.

institutional ownershipfloat

Risk Factors

  • All buyers are mega-passive/quant funds, not active or activist managers — may reflect index rebalancing rather than conviction
  • Hedge fund RenTech (quant) trimmed nearly 40% of its position, a partial de-risking signal
  • Model calibration for this segment shows negative net alpha at T+20 (-2.04%) and low win rates at scores 6-8
  • KOD has no approved products or disclosed revenue — clinical trial readouts are binary catalysts
  • Prior KOD reports from this model averaged -14.05% T+20 P&L, suggesting overconfidence in past bullish signals

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-KOD-2025-Q3
5 reports for KOD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for KOD — sortable, filterable
TypeNow
Aug 13, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$41.35 $33.14▼ −19.85%▼ −17.86%—
Aug 13, 2026
7w ago
Press Release
NEUTRAL ★ 6/10
$41.35 $33.14▼ −19.85%▼ −17.86%—
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 4/10
$33.97 $40.08▲ +17.99%▲ +16.10%—
May 7, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$41.01 $31.05▼ −24.29%▼ −24.31%—
Mar 31, 2026
26w ago
8-K
BULLISH ★ 8/10
$42.81 $43.67▲ +2.01%▼ −7.71%—
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026